Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2010
03/18/2010WO2009126742A3 Enzyme mediated delivery system
03/18/2010WO2009121065A3 Modulation and repletion/enhancement of the complement system for treatment of trauma
03/18/2010WO2009115525A3 Preparation of a pharmaceutical composition for increasing bone mineral density
03/18/2010WO2009110947A3 Compositions and methods for inhibiting cytokine production
03/18/2010WO2009108898A3 Production and uses of type 1 ribosome inactivating proteins
03/18/2010WO2009087622A3 Sldlr in viral hepatitis
03/18/2010WO2009074133A3 C-terminal ifapsoriasin fragments as antimicrobial peptides, the production thereof and use thereof
03/18/2010WO2009061395A3 Hcv combination therapies comprising vx-950, peg-ifn and ribavirin
03/18/2010WO2009051846A3 Translocation and mutant ros kinase in human non-small cell lung carcinoma
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis
03/18/2010US20100069615 Regulation of Human Transmembrane Serine Protease
03/18/2010US20100069466 Compositions and Methods for the Systemic Treatment of Arthritis
03/18/2010US20100069309 Method for medical treatment utilizing glutathione
03/18/2010US20100069308 Surfaces containing antibacterial polymers
03/18/2010US20100069307 Neuropeptide-2 receptor (y-2r) agonists
03/18/2010US20100069306 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
03/18/2010US20100069305 Composition for maintaining gastrointestinal homeostasis
03/18/2010US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein
03/18/2010US20100069303 Methods of treating bone disease using vascular endothelial growth factor fusion constructs
03/18/2010US20100069302 Specific therapy and medicament using integrin ligands for treating cancer
03/18/2010US20100069301 Compositions and methods for treating pathologic angiogenesis and vascular permeability
03/18/2010US20100069300 C-Type Lectin Fold as a Scaffold for Massive Sequence Variation
03/18/2010US20100069299 Ghrelin analogs
03/18/2010US20100069298 Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
03/18/2010US20100069297 Selective Inhibition of TLR4 Signaling
03/18/2010US20100069296 Use of somatostatin analogs in cluster headache
03/18/2010US20100069295 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
03/18/2010US20100069294 Hcv protease inhibitors and uses thereof
03/18/2010US20100069293 Polymeric carrier compositions for delivery of active agents, methods of making and using the same
03/18/2010US20100069292 Insulin with a basal release profile
03/18/2010US20100069291 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent
03/18/2010US20100069290 Ejection liquid and ejection method
03/18/2010US20100069289 Animal feeds and veterinary compositions
03/18/2010US20100069288 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
03/18/2010US20100068301 Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
03/18/2010US20100068289 Spherical microcapsules comprising glp-i peptides, their production and use
03/18/2010US20100068281 Methods and compositions for tissue regeneration
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068259 Natural product inhibitors of 3dg
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068253 Bleomycin preparation for use against skin tumours
03/18/2010US20100068245 Preparation and storage of stable, biologically active materials
03/18/2010US20100068240 Implantable nerve regeneration conduit
03/18/2010US20100068239 Osteogenic Device for Inducing Bone Formation in Clinical Contexts
03/18/2010US20100068228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
03/18/2010US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/18/2010US20100068215 Use of GDF traps to increase red blood cell levels
03/18/2010US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
03/18/2010US20100068211 Use of antiresorptive compounds to prevent ionizing radiation-induced activation of osteoclasts and resulting bone loss
03/18/2010US20100068210 Compositions and methods for the prevention of oxidative degradation of proteins
03/18/2010US20100068209 Antibacterial compositions for drug administration
03/18/2010US20100068207 DDR2 in Cancer Diagnosis, Detection and Treatment
03/18/2010US20100068201 Compositions and methods for the systemic treatment of arthritis
03/18/2010US20100068196 Method of micronization
03/18/2010US20100068195 recombinant human N-acetylgalactosamine-6-sulfatase (GALNS) enzyme having purity of at least about 95 , 90 % conversion of Cys at position 53 to C alpha -formylglycine, bis-phosphorylated oligomannose chains per monomeric protein chain; use in the diagnosis, prophylaxis etc.
03/18/2010US20100068186 High affinity telomerase t cell receptors
03/18/2010US20100068182 Combination therapy for treating hcv infection
03/18/2010US20100068181 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/2010US20100068180 Novel methods for modulating inflammatory and/or immune responses
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068178 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068176 Hepatitis c virus inhibitors
03/18/2010US20100068175 Methods of using Fc-Cytokine fusion proteins
03/18/2010US20100068174 Combination with bis (thiohydrazide amides) for treating cancer
03/18/2010US20100068173 Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects
03/18/2010US20100068151 Multimodality molecular imaging with therapeutic conjugates
03/18/2010US20100068149 Use of nutritional compositions for preventing disorders
03/18/2010US20100068147 Dengue diagnosis and treatment
03/18/2010US20100068141 Use of heat shock to treat ocular disease
03/18/2010US20100068136 Anti-CD19 Antibodies
03/18/2010CA2737253A1 Novel dipeptidyl peptidase iv (dp-iv) compounds
03/18/2010CA2737094A1 Factor ix polypeptide mutant, its uses and a method for its production
03/18/2010CA2736922A1 Use of an ang-(1-7) receptor agonist in acute lung injury
03/18/2010CA2736895A1 Macrocyclic hepatitis c serine protease inhibitors
03/18/2010CA2734275A1 Compositions and methods for the prevention of oxidative degradation of proteins
03/18/2010CA2731113A1 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/18/2010CA2679041A1 Recombinant human blood coagulation factor viii protein, composition, use of a recombinant factor viii protein, use of a composition, method of obtaining a recombinant human bloodcoagulation factor viii protein and use thereof
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163625A1 IL-17 and IL-17R homologous polypeptides and therapeutic uses thereof
03/17/2010EP2163623A2 Bitter taste receptors
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163260A2 Chimpanzee adenovirus vaccine carriers
03/17/2010EP2163259A1 Use of an Ang-(1-7) receptor agonist in acute lung injury
03/17/2010EP2163254A1 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
03/17/2010EP2162534A1 Cd34 stem cell-related methods and compositions
03/17/2010EP2162472A2 Immunoglobulin fusion proteins
03/17/2010EP2162464A1 Natriuretic fusion proteins
03/17/2010EP2162463A1 Vegf-d mutants and their use
03/17/2010EP2162461A1 Targeted induction of aggregation of proteins with cross beta structures
03/17/2010EP2162283A2 Self assembled films for protein and drug delivery applications
03/17/2010EP2162149A1 Vaccine for the prevention of breast cancer relapse
03/17/2010EP2162146A2 Use of transferrin for preparing pharmaceutical compositions useful for treating bacterial infections as coadjuvants in antibiotic therapy
03/17/2010EP2162141A1 Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue
03/17/2010EP1663177B1 Topical preparations comprising a hydrophilic carrier and a silicone matrix
03/17/2010EP1585478B1 Use of synergistic bacteriophage lytic enzymes for prevention and treatment of bacterial infections
1 ... 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 ... 3163